SLC22A3-CYP20A1 Fusion FISH Probe
The SLC22A3-CYP20A1 Fusion FISH Probe is used to confirm a fusion of the SLC22A3 and CYP20A1 genes. The fusion of the SLC22A3 and CYP20A1 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
SLC22A3-CYP20A1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-RERE | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-REOR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-REGO | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-REGR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-REAQ | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-ORRE | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-OROR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-ORGO | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-ORAQ | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GORE | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GOOR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GOGO | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GOGR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GOAQ | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GRRE | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GROR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GRGO | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GRGR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-GRAQ | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-AQRE | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-AQOR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-AQGO | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-AQGR | 20 (40 μL) | 200 μL | ||
SLC22A3-CYP20A1-20-AQAQ | 20 (40 μL) | 200 μL |
SLC22A3 Gene Summary
Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. This gene is one of three similar cation transporter genes located in a cluster on chromosome 6. The encoded protein contains twelve putative transmembrane domains and is a plasma integral membrane protein. [provided by RefSeq, Jul 2008]
Gene Name: Solute Carrier Family 22 Member 3
Chromosome: CHR6: 160769424 -160876014
Locus: 6q25.3
CYP20A1 Gene Summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein lacks one amino acid of the conserved heme binding site. It also lacks the conserved I-helix motif AGX(D,E)T, suggesting that its substrate may carry its own oxygen. [provided by RefSeq, Jul 2008]
Gene Name: Cytochrome P450 Family 20 Subfamily A Member 1
Chromosome: CHR2: 204103163 -204170563
Locus: 2q33.2
Gene Diseases
The SLC22A3 CYP20A1 Fusion has been associated with the following diseases:
Disease Name |
---|
Liver Hepatocellular Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|